´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.

NEWS


NEWS
¹øÈ£ Á¦ ¸ñ ÷ºÎ ÀÛ¼ºÀÏ
271     [°øÁö] ½Å±Ô È«º¸ÀÚ·á Ãâ°£ – ÈļºÀ¯ÀüÇÐ (Epigenetics)À» À§ÇÑ ¸ðµç °Í   2019.04.11
272     [À̺¥Æ®] CRISPR/Cas9 ¼³¹®Á¶»ç À̺¥Æ® – 2Â÷ ¼±¹° ¹ß¼Û ¾È³» ¹× °¨»ç ÀÎ»ç   2019.04.05
273     [°øÁö] ȨÆäÀÌÁö ¾÷µ¥ÀÌÆ® - Next Generation Sequencing (NGS) : Upstream & Downstream ¾È³»   2019.04.05
274     [°øÁö] ȨÆäÀÌÁö ¾÷µ¥ÀÌÆ® – CRISPR Genome Editing ¿À¹öºä ÆäÀÌÁö °³Æí, ´Ù¾çÇÑ ÀÚ·á ¼ö·Ï   2019.03.27
275     [°øÁö] ȨÆäÀÌÁö ¾÷µ¥ÀÌÆ® - Cell-free Nucleic Acid NGS Ãßõ°¡ÀÌµå ¿ÀÇ   2019.03.26
276     [°øÁö] NGS – [Application Book] ¹ß°£ ¾È³»   2019.03.11
277     [À̺¥Æ®] CRISPR/Cas9 ¼³¹®Á¶»ç À̺¥Æ® – 1Â÷ ¼±¹° ¹ß¼Û! (½ºÅ¸¹÷½ºÄ¿ÇÇ & ÇÒÀÎÄíÆù)   2019.02.26
278     [½ÅÁ¦Ç°] One Step Real Time RT-PCR kit Ãâ½Ã (Dual-Labeled Probe °ËÃâ¹ý)   2019.02.13
279     [°øÁö] 2¿ù 1ÀÏ ¾÷¹« Á¶±â Á¾·á ¾È³»(¿ÀÈÄ 3½Ã±îÁö)   2019.02.01
280     [°øÁö] ȨÆäÀÌÁö ¾÷µ¥ÀÌÆ® ¾È³» Up & Down – CRISPR/Cas9 Gene Editing   2019.01.31
281     [°øÁö] ȨÆäÀÌÁö »õ ´ÜÀå ¾È³»   2019.01.25
282     [°øÁö] 2019³â ¼ÒºñÀÚ°¡ º¯°æ ¾È³»   2019.01.18
283     [°øÁö] DEF-CS¢â 500 Culture SystemÀ» »ç¿ëÇÑ ³í¹®¸®½ºÆ® ¾÷µ¥ÀÌÆ® ¾È³»   2019.01.11
284     [°øÁö] Lonza PAGEr¢â Gel Á¾¸Å ¾È³»   2019.01.07
285     [°øÁö] ȨÆäÀÌÁö ¾÷µ¥ÀÌÆ® ¾È³» – <Çü±¤´Ü¹éÁú ¸í°¡> Çü±¤´Ü¹éÁú Ç×ü ¼±Åð¡ÀÌµå ¿ÀÇ   2019.01.03
    16  17  18  19  20  21  22  23  24  25  26  27  28  29  30